# Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases

> **NCT02602327** · PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 21 (actual)

## Conditions studied

- Colon Cancer
- Rectal Cancer
- Liver Metastases

## Interventions

- **DRUG:** Tas-102
- **DEVICE:** SIR-Sphere

## Key facts

- **NCT ID:** NCT02602327
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-09
- **Primary completion:** 2021-05-20
- **Final completion:** 2021-08-31
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2022-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602327, "Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02602327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*